Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric maltol versus standard care for postoperative anaemia after colorectal cancer surgery
ISRCTN12290106Phase 4Completed
- Sponsor
- The Royal Wolverhampton NHS Trust
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric maltol in anaemia (2 arms), sponsored by The Royal Wolverhampton NHS Trust. Primary endpoints: Eligible patients from screening, Study exclusion and 2 more. Started Feb 2022; status: completed.
02
Drugs
ferric maltol
03
Conditions
anaemia
Beyond the preview
Go deeper on ISRCTN12290106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12290106.